# Ultragenyx Pharmaceutical Inc. – FDA Inspection, Apr 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/2f0d5638-cff4-4ea0-92d0-6d515d411183
Source feed: FDA_Inspections

> FDA inspection 1269681 of Ultragenyx Pharmaceutical Inc., April 25, 2025. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269681
- Company Name: Ultragenyx Pharmaceutical Inc.
- Inspection Date: 2025-04-25
- Product Type: Biologics
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jacob-l-bitterman/f1868456-2053-4738-a158-93d921a06258)
- [Issuing Officer](https://www.keypedia.com/people/kula-n-jha/59961b64-fc92-440d-ae53-0bb03cbc9c78)
- [FDA Associated Person](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)
- [Issuing Officer](https://www.keypedia.com/people/timothy-kamaldinov/30dbc3a4-c383-4c18-9d4b-a3b1e6f50860)

Company: https://www.keypedia.com/companies/ultragenyx-pharmaceutical-inc/eced36f4-f37f-4271-b0fa-cad0b7de872b

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
